{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:56:33Z","timestamp":1778964993998,"version":"3.51.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4,1]]},"DOI":"10.1215\/15228517-2006-037","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T20:43:01Z","timestamp":1171485781000},"page":"96-102","source":"Crossref","is-referenced-by-count":6,"title":["High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma"],"prefix":"10.1093","volume":"9","author":[{"given":"Philipp","family":"Kiewe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Loddenkemper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Reinwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eckhard","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Korfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,4,1]]},"reference":[{"key":"key\n\t\t\t\t20171013135406_REF1","doi-asserted-by":"crossref","unstructured":"Abrey, L.E., DeAngelis, L.M., and Yahalom, J. (1998) Long-term survival in primary CNS lymphoma. J. Clin. Oncol.16, 859-863.","DOI":"10.1200\/JCO.1998.16.3.859"},{"key":"key\n\t\t\t\t20171013135406_REF2","doi-asserted-by":"crossref","unstructured":"Abrey, L.E., Batchelor, T.T., Ferreri, A.J., Gospodarowicz, M., Pulczynski, E.J., Zucca, E., Smith, J.R., Korfel, A., Soussain, C., DeAngelis, L.M., Neuwelt, E.A., O'Neill, B.P., Thiel, E., Shenkier, T., Graus, F., van den Bent, M., Seymour, J.F., Poortmans, P., Armitage, J.O., and Cavalli, F.; International Primary CNS Lymphoma Collaborative Group. (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J. Clin. Oncol.23, 5034-5043.","DOI":"10.1200\/JCO.2005.13.524"},{"key":"key\n\t\t\t\t20171013135406_REF3","doi-asserted-by":"crossref","unstructured":"Alderson, L., Fetell, M.R., Sisti, M., Hochberg, F., Cohen, M., and Louis, D.N. (1996) Sentinel lesions of primary CNS lymphoma. J. Neurol. Neurosurg. Psychiatry60, 102-105.","DOI":"10.1136\/jnnp.60.1.102"},{"key":"key\n\t\t\t\t20171013135406_REF4","doi-asserted-by":"crossref","unstructured":"Bernays, R.L., Kollias, S.S., Khan, N., Brandner, S., Meier, S., and Yonekawa, Y. (2002) Histological yield, complications, and technological considerations in 114 consecutive frameless stereotactic biopsy procedures aided by open intraoperative magnetic resonance imaging. J. Neurosurg.97, 354-362.","DOI":"10.3171\/jns.2002.97.2.0354"},{"key":"key\n\t\t\t\t20171013135406_REF5","doi-asserted-by":"crossref","unstructured":"Bromberg, J.E.C., Siemers, M.D., and Taphoorn, M.J.B. (2002) Is a \u201cvanishing tumor\u201d always a lymphoma? Neurology59, 762-764.","DOI":"10.1212\/WNL.59.5.762"},{"key":"key\n\t\t\t\t20171013135406_REF6","doi-asserted-by":"crossref","unstructured":"Bu\u0308hring, U., Herrlinger, U., Krings, T., Thiex, R., Weller, M., and Kuker, W. (2001) MRI features of primary central nervous system lymphomas at presentation. Neurology57, 393-396.","DOI":"10.1212\/WNL.57.3.393"},{"key":"key\n\t\t\t\t20171013135406_REF7","doi-asserted-by":"crossref","unstructured":"Bullmann, C., Faust, M., Hoffmann, A., Heppner, C., Jockenhovel, F., Muller-Wieland, D., and Krone, W. (2000) Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis. Eur. J. Endocrinol.142, 365-372.","DOI":"10.1530\/eje.0.1420365"},{"key":"key\n\t\t\t\t20171013135406_REF8","doi-asserted-by":"crossref","unstructured":"Capello, E., and Mancardi, G.L. (2004) Marburg type and Balo's concentric sclerosis: Rare and acute variants of multiple sclerosis. Neurol. Sci.25, 361-363.","DOI":"10.1007\/s10072-004-0341-1"},{"key":"key\n\t\t\t\t20171013135406_REF9","doi-asserted-by":"crossref","unstructured":"Dagher, A.P., and Smirniotopoulos, J. (1996) Tumefactive demyelinating lesions. Neuroradiology38, 560-565.","DOI":"10.1007\/BF00626098"},{"key":"key\n\t\t\t\t20171013135406_REF10","unstructured":"DeAngelis, L.M. (1995) Current management of primary central nervous system lymphoma. Oncology9, 63-71."},{"key":"key\n\t\t\t\t20171013135406_REF11","doi-asserted-by":"crossref","unstructured":"Eby, N.L., Gruffermann, S., Flannelly, C.M., Schold, S.C., Vogel, F.S., and Burger, P.C. (1988) Increasing incidence of primary brain lymphoma in the US. Cancer62, 2461-2465.","DOI":"10.1002\/1097-0142(19881201)62:11<2461::AID-CNCR2820621135>3.0.CO;2-M"},{"key":"key\n\t\t\t\t20171013135406_REF12","doi-asserted-by":"crossref","unstructured":"Glass, J., Gruber, M.L., Cher, L., and Hochberg, F.H. (1994) Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: Long-term outcome. J. Neurosurg.81, 188-195.","DOI":"10.3171\/jns.1994.81.2.0188"},{"key":"key\n\t\t\t\t20171013135406_REF13","doi-asserted-by":"crossref","unstructured":"Gleissner, B., Siehl, J., Korfel, A., Reinhardt, R., and Thiel, E. (2002) CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes. Neurology58, 390-396.","DOI":"10.1212\/WNL.58.3.390"},{"key":"key\n\t\t\t\t20171013135406_REF14","doi-asserted-by":"crossref","unstructured":"Hall, W.A. (1998) The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer82, 1749-55.","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1756::AID-CNCR23>3.0.CO;2-2"},{"key":"key\n\t\t\t\t20171013135406_REF15","doi-asserted-by":"crossref","unstructured":"Harting, I., Hartmann, M., Jost, G., Sommer, C., Ahmadi, R., Heiland, S., and Sartor, K. (2003) Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy. Neurosci. Lett.342, 163-166.","DOI":"10.1016\/S0304-3940(03)00272-6"},{"key":"key\n\t\t\t\t20171013135406_REF16","doi-asserted-by":"crossref","unstructured":"Hartmann, M., Heiland, S., Harting, I., Tronnier, V.M., Sommer, C., Ludwig, R., and Sartor K. (2003) Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci. Lett.338, 119-122.","DOI":"10.1016\/S0304-3940(02)01367-8"},{"key":"key\n\t\t\t\t20171013135406_REF17","doi-asserted-by":"crossref","unstructured":"Hoeve, M.A., Krol, A.D.G., Derksen, P.W.B., Veenendaal, R.A., Schuuring, E., Kluin, P.M., and van Krieken, J.H.J.M. (2000) Limitations of clonality analysis of B cell proliferations using CDR3 polymerase chain reaction. J. Clin. Pathol. Mol. Pathol.53, 194-200.","DOI":"10.1136\/mp.53.4.194"},{"key":"key\n\t\t\t\t20171013135406_REF18","unstructured":"Hoffman, J.M., Waskin, H.A., Schifter, T., Hanson, M.W., Gray, L., Rosenfeld, S., and Coleman, R.E. (1993) FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J. Nucl. Med.34, 567-575."},{"key":"key\n\t\t\t\t20171013135406_REF19","doi-asserted-by":"crossref","unstructured":"Jahnke, K., Thiel, E., Schilling, A., Herrlinger, U., Weller, M., Coupland, S.E., Krumpelmann, U., Stein, H., and Korfel, A. (2005) Low-grade primary central nervous system lymphoma in immunocompetent patients. Br. J. Haematol.128, 616-624.","DOI":"10.1111\/j.1365-2141.2004.05361.x"},{"key":"key\n\t\t\t\t20171013135406_REF20","doi-asserted-by":"crossref","unstructured":"Ku\u0308ker, W., Na\u0308gele T., Korfel A., Heckl S., Thiel E., Bamberg M., Weller, M., and Herrlinger, U. (2005) Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J. Neurooncol.72, 169-177.","DOI":"10.1007\/s11060-004-3390-7"},{"key":"key\n\t\t\t\t20171013135406_REF21","doi-asserted-by":"crossref","unstructured":"Kurihara, N., Takahashi, S., Furuta, A., Higano, S., Matsumoto, K., Tobita, M., Konno, H., and Sakamoto, K. (1996) MR imaging of multiple sclerosis simulating brain tumor. Clin. Imaging20, 171-177.","DOI":"10.1016\/0899-7071(95)00012-7"},{"key":"key\n\t\t\t\t20171013135406_REF22","doi-asserted-by":"crossref","unstructured":"MacLaren, K., Gillespie, J., Shrestha, S., Neary, D., and Ballardie, F.W. (2005) Primary angiitis of the central nervous system: Emerging variants. QJM98, 643-654.","DOI":"10.1093\/qjmed\/hci098"},{"key":"key\n\t\t\t\t20171013135406_REF23","doi-asserted-by":"crossref","unstructured":"Marchioni, E., Ravaglia, S., Piccolo, G., Furione, M., Zardini, E., Franciotta, D., Alfonsi, E., Minoli, L., Romani, A., Todeschini, A., Uggetti, C., Tavazzi, E., and Ceroni, M. (2005) Postinfectious inflammatory disorders: Subgroups based on prospective follow-up. Neurology65, 1057-1065.","DOI":"10.1212\/01.wnl.0000179302.93960.ad"},{"key":"key\n\t\t\t\t20171013135406_REF24","unstructured":"Mendez, M.F., and Pogacar, S. (1998) Malignant monophasic multiple sclerosis or \u201cMarburg's disease.\u201d Neurology38, 1153-1155."},{"key":"key\n\t\t\t\t20171013135406_REF25","doi-asserted-by":"crossref","unstructured":"Menge, T., Hemmer, B., Nessler, S., Wiendl, H., Neuhaus, O., Hartung, H.P., Kieseier, B.C., and Stuve, O. (2005) Acute disseminated encephalomyelitis: An update. Arch. Neurol.62, 1673-1680.","DOI":"10.1001\/archneur.62.11.1673"},{"key":"key\n\t\t\t\t20171013135406_REF26","doi-asserted-by":"crossref","unstructured":"Mombaerts, I., Schlingemann, R.O., Goldschmeding, R., and Koornneef, L. (1996) Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology103, 521-528.","DOI":"10.1016\/S0161-6420(96)30663-5"},{"key":"key\n\t\t\t\t20171013135406_REF27","doi-asserted-by":"crossref","unstructured":"Moritani, T., Hiwatashi, A., Shrier, D.A., Wang, H.Z., Numaguchi, Y., and Westesson, P.L. (2004) CNS vasculitis and vasculopathy: Efficacy and usefulness of diffusion-weighted echoplanar MR imaging. Clin. Imaging28, 261-270.","DOI":"10.1016\/S0899-7071(03)00191-8"},{"key":"key\n\t\t\t\t20171013135406_REF28","doi-asserted-by":"crossref","unstructured":"Nelson, D.F., Martz, K.L., Bonner, H., Nelson, J.S., Newall, J., Kerman, H.D., Thomson, J.W., and Murray, K.J. (1992) Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int. J. Radiat. Oncol. Biol. Phys.23, 9-17.","DOI":"10.1016\/0360-3016(92)90538-S"},{"key":"key\n\t\t\t\t20171013135406_REF29","doi-asserted-by":"crossref","unstructured":"Raizer, J.J., Koutcher, J.A., Abrey, L.E., Panageas, K.S., DeAngelis, L.M., Lis, E., Xu, S., and Zakian, K.L. (2005) Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. J. Neurooncol.7, 173-180.","DOI":"10.1007\/s11060-004-1360-8"},{"key":"key\n\t\t\t\t20171013135406_REF30","doi-asserted-by":"crossref","unstructured":"Rehman, H.U. (2000) Primary angiitis of the central nervous system. J. R. Soc. Med.93, 586-588.","DOI":"10.1177\/014107680009301108"},{"key":"key\n\t\t\t\t20171013135406_REF31","doi-asserted-by":"crossref","unstructured":"Reiche, W., Hagen, T., Schuchardt, V., and Billmann, P. (2007) Diffusion-weighted MR imaging improves diagnosis of CNS lymphomas: A report of four cases with common and uncommon imaging features. Clin. Neurol. Neurosurg. 109, 92-101.","DOI":"10.1016\/j.clineuro.2006.03.007"},{"key":"key\n\t\t\t\t20171013135406_REF32","doi-asserted-by":"crossref","unstructured":"Roelcke, U., and Leenders, K.L. (1999) Positron emission tomography in patients with primary CNS lymphomas. J. Neurooncol.43, 231-236.","DOI":"10.1023\/A:1006202402010"},{"key":"key\n\t\t\t\t20171013135406_REF33","unstructured":"Roman-Goldstein, S.M., Goldman, D.L., Howieson, J., Belkin, R., and Neuwelt, E.A. (1992) MR of primary CNS lymphoma in immunologically normal patients. AJNR Am. J. Neuroradiol.13, 1207-1213."},{"key":"key\n\t\t\t\t20171013135406_REF34","unstructured":"Schwaighofer, B.W., Hesselink, J.R., Press, G.A., Wolf, R.L., Healy, M.E., and Berthoty, D.P. (1989) Primary intracranial CNS lymphoma: MR manifestations. AJNR Am. J. Neuroradiol.10, 725-729."},{"key":"key\n\t\t\t\t20171013135406_REF35","doi-asserted-by":"crossref","unstructured":"Schwarz, S., Mohr, A., Knauth, M., Wildemann, B., and Storch-Hagenlocher, B. (2001) Acute disseminated encephalomyelitis: A follow-up study of 40 adult patients. Neurology56, 1313-1318.","DOI":"10.1212\/WNL.56.10.1313"},{"key":"key\n\t\t\t\t20171013135406_REF36","doi-asserted-by":"crossref","unstructured":"Silva, H.C., Callegaro, D., Marchiori, P.E., Scaff, M., and Tsanaclis, A.M. (1999) Magnetic resonance imaging in five patients with a tumefactive demyelinating lesion in the central nervous system. Arq. Neuropsiquiatr.57, 921-926.","DOI":"10.1590\/S0004-282X1999000600004"},{"key":"key\n\t\t\t\t20171013135406_REF37","doi-asserted-by":"crossref","unstructured":"Siva, A. (2001) Vasculitis of the nervous system. J. Neurol.248, 451-468.","DOI":"10.1007\/s004150170154"},{"key":"key\n\t\t\t\t20171013135406_REF38","doi-asserted-by":"crossref","unstructured":"Tan, H.M., Chan, L.L., Chuah, K.L., Goh, N.S.S., and Tang, K.K. (2004) Monophasic, solitary tumefactive demyelinating lesion: Neuroimaging features and neuropathological diagnosis. Br. J. Radiol.77, 153-156.","DOI":"10.1259\/bjr\/26682607"},{"key":"key\n\t\t\t\t20171013135406_REF39","doi-asserted-by":"crossref","unstructured":"Volcy, M., Toro, M.E., Uribe, C.S., and Toro, G. (2004) Primary angiitis of the central nervous system: Report of five biopsy-confirmed cases from Colombia. J. Neurol. Sci.227, 85-89.","DOI":"10.1016\/j.jns.2004.08.007"},{"key":"key\n\t\t\t\t20171013135406_REF40","doi-asserted-by":"crossref","unstructured":"Wild, A.M., Xuereb, J.H., Marks, P.V., and Gleave, J.R. (1990) Computerized tomographic stereotaxy in the management of 200 consecutive intracranial mass lesions. Analysis of indications, benefits and outcome. Br. J. Neurosurg.4, 407-415.","DOI":"10.3109\/02688699008992763"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/9\/2\/96\/13066392\/NO92_05_Kiewe-rev1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T12:57:05Z","timestamp":1556110625000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article\/9\/2\/96\/1116567\/Highdose-methotrexate-is-beneficial-in-parenchymal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,1]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,4,1]]},"published-print":{"date-parts":[[2007,4,1]]}},"URL":"https:\/\/doi.org\/10.1215\/15228517-2006-037","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published-other":{"date-parts":[[2007,4]]},"published":{"date-parts":[[2007,4,1]]}}}